Cost Effectiveness of Genotype-Guided Warfarin Dosing in Patients with Mechanical Heart Valve Replacement Under the Fee-for-Service System
Crossref DOI link: https://doi.org/10.1007/s40258-017-0317-y
Published Online: 2017-02-28
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kim, Dong-Jin
Kim, Ho-Sook
Oh, Minkyung
Kim, Eun-Young
Shin, Jae-Gook
License valid from 2017-02-28